PNTG Company Profile and Key Details

Q: Who are the executives of PNTG?

Mr. John J. GochnourPres & Chief Operating OfficerMs. Jennifer L. Freeman CPAInterim Chief Financial OfficerMr. Derek J. BunkerChief Investment Officer, Executive Vice President & Sec.Mr. Brent J. GuerisoliChief Executive Officer & DirectorMr. Brian WaymentPres of Cornerstone HealthcareMr. Kirk S. CheneyGen. Counsel & Corporation Sec.Mr. Kirk CheneyGen. Counsel & Corporation Sec.Ms. Lynette B. Walbom CPAChief Financial Officer

NASDAQ : PNTG

Pennant Group

$30.80

0.45+1.48%

At Close 4:00 PM

66.28

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

The Pennant Group, Inc. (PNTG) stock surged +1.48%, trading at $30.80 on NASDAQ, up from the previous close of $30.35. The stock opened at $30.39, fluctuating between $30.06 and $31.01 in the recent session.

Stock Snapshot

30.35

Prev. Close

1.07B

Market Cap

30.055

Day Low

41.07

P/E Ratio

0.75

EPS (TTM)

0.83

Cash Flow per Share

30.39

Open

34.59M

Number of Shares

31.01

Day High

87.64%

Free Float in %

4.68

Book Value

345.84K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 09, 2026	30.39	31.01	30.00	30.80	349.92K
Feb 06, 2026	29.95	30.47	29.50	30.35	247.63K
Feb 05, 2026	29.01	30.53	29.01	29.98	325.47K
Feb 04, 2026	29.11	29.72	28.66	28.92	283.64K
Feb 03, 2026	28.67	29.36	28.32	29.22	449.04K
Feb 02, 2026	27.69	28.68	27.50	28.22	278.99K
Jan 30, 2026	27.32	27.77	26.71	27.62	291.12K
Jan 29, 2026	27.48	27.48	26.67	27.34	256.16K
Jan 28, 2026	27.45	27.84	27.01	27.49	446.94K
Jan 27, 2026	30.54	30.70	27.07	27.63	787.06K
Jan 26, 2026	30.53	30.78	30.23	30.54	223.98K
Jan 23, 2026	31.55	31.86	29.83	30.53	287.41K
Jan 22, 2026	30.16	31.94	30.14	31.16	822.33K
Jan 21, 2026	29.40	30.16	28.44	30.00	370.97K
Jan 20, 2026	28.66	29.60	28.03	29.30	210.3K
Jan 16, 2026	29.81	30.20	28.70	29.15	243.1K
Jan 15, 2026	28.84	30.16	28.68	29.90	244.37K
Jan 14, 2026	28.62	28.82	28.21	28.82	284.45K
Jan 13, 2026	28.80	29.00	28.37	28.75	176.76K
Jan 12, 2026	28.12	28.89	27.63	28.86	218.1K

Contact Details

Eagle, ID 83616

United States

https://www.pennantgroup.com 208 506 6100

About Company

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.

Stock Peers

ENSG

1.49+0.75%

The Ensign Group, Inc.$199.29 ADUS

-2.17-2.05%

Addus HomeCare Corporation$103.71 AMED

0.01+0.01%

Amedisys, Inc.$100.99 FSHCX

-0.9-0.91%

Health Care Services Portfolio$98.03 AMEH

-0.88-2.11%

Apollo Medical Holdings, Inc.$40.82 OPCH

-0.83-2.44%

Option Care Health, Inc.$33.17 MCTA

1.855+6.75%

Charming Medical Limited Class A Ordinary Shares$29.36 HCSG

-0.44-2.27%

Healthcare Services Group, Inc.$18.96 KDLYW

2.995+19.14%

Kindly MD, Inc.$18.65 ASTH

-2.51-11.90%

Astrana Health, Inc.$18.59

Company Overview

The Pennant Group, Inc. (NASDAQ:PNTG) closed at $30.80 USD, gaining $0.45 (1.48%) from the previous close of $30.35. The stock is currently within 5% of its 52-week high $21.18 and $31.94. With a market capitalization of about $1.07 billion, The Pennant Group, Inc. is classified as a small-cap and shows market-like volatility (beta ~1.28). Key stats such as the average daily volume over the past year has been around 268.80 thousand shares, in line with its 52-week average. Headquartered in Eagle, ID, The Pennant Group, Inc. operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Brent J. Guerisoli, the company employs approximately 7,000 people and listed since October 01, 2019. The Pennant Group, Inc. provides healthcare services in the United States.

Technical Performance

Short-term trend indicators are bearishly aligned (SMA20 5.37%, SMA50 5.98%, SMA200 15.71%). The stock’s 14-day RSI is 61.54 (firm momentum), while the ATR of 1.19 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -3.57% below its high and over 45.42% above its low. Average 10-day trading volume of 317.97 thousand shares is slightly above the 3-month average of 267.18 thousand, indicating heightened recent market interest.

Valuation Metrics

The Pennant Group, Inc. trades at a P/E ratio of 39.81, slightly above the S&P 500 average, with a price-to-sales ratio of 1.25 and a price-to-book ratio of 3.3 trading at moderately above to book value. The P/FCF stands at 29.44, also above market averages.

Dividend & Fair Value

The Pennant Group, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $8.72. This means the shares are trading above this model’s fair value.

Earnings & Analyst Outlook

The Pennant Group, Inc. generated EPS of $0.76 over the past year. Five-year average earnings growth is 52.31%. Wall Street analysts project EPS growth of 18.81% annually over the next five years. The latest quarter delivered EPS of $0.30. The next quarter is forecast at $0.32. Next year's EPS is expected at $17.53. Analyst sentiment is bullish. Analyst rating data shows there are 7 Strong Buy ratings, 2 Buy ratings, 3 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $40.00 to $28.00. The high target offers 29.87% upside. The low target suggests -9.09% downside. The mean target is $34.42. This offers 11.75% upside. The Pennant Group, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 05, 2025, missed forecasts by 3.45%. The prior quarter beat by 3.85%. Over the last six quarters, Apple has recorded several small beats. These include 14.29% in August 06, 2024.

Shareholding & Insider Activity

The Pennant Group, Inc. has 34.56 million shares outstanding. The public float is 30.29 million shares, elevated short interest at 2.02% of float. This equals 592.85 thousand shares. The short ratio is 1.79 days. Institutional investors hold 97.36% of the float. Insiders own 4.64%. Walker Daniel H holds 462.94 thousand shares, Christensen Christopher R. has 152.40 thousand shares and Nackel John G. has 82.65 thousand shares.

Financial & Profitability Overview

Over the trailing twelve months, Pennant Group generated $544.89M in revenue, or $18.05 per share. Gross margin was 12.30%, operating margin 4.62%, and net profit margin 2.46%. Returns are modest, with ROA at 2.48% and ROE at 9.53%.
On valuation metrics, Pennant Group trades at a P/E of 39.81, P/S of 1.25 and P/B of 3.30. The current ratio is 1.04 and quick ratio is 1.04. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is 30.37 days. Debt-to-equity is 0.94, supported by a cash flow-to-debt ratio of 0.16.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Pennant Group posted revenue of $544.89M, down slightly from $473.24M in the prior quarter. Gross profit was $67.04M (margin 12.30%). Operating income was $25.17M (margin 4.6%). Net income was$13.38M (EPS $0.45).
The company ended the quarter with $6.06M in cash and short-term investments, a total debt of $329.63M, and net debt of $323.57M. Total assets were $539.69M, with equity of $145.52M. Financials further reflected stability, with operating cash flow of $33.09M, free cash flow of $24.99M, and capital expenditures of - $8.11M.

Price Forecast & Outlook

Our AI price prediction model suggests that The Pennant Group, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -0.55%, with price expected at $30.63 by February 23, 2026, within a range of $29.58 to $31.67 3-Month Outlook: Projected rise of 21.79%, reaching $37.51 by May 07, 2026, with a range of $36.57 to $38.67. 1-Year Outlook: Projected gain of 22.05%, with price at $37.59 by February 09, 2027, within a range of $35.89 to $39.17.

Key Takeaways

The Pennant Group, Inc. (NASDAQ:PNTG) shares are flat 4.09% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows The Pennant Group, Inc. trading at a premium to the broader market with a P/E of 39.81. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $27.26, suggesting -11.49% downside. Our AI forecast model points to short-term weakness (-0.55% over two weeks), a medium-term rise (21.79% over three months), and a longer-term gain (22.05% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current The Pennant Group, Inc. (PNTG) stock price?

The Pennant Group, Inc. (NASDAQ: PNTG) stock price is $30.80 in the last trading session. During the trading session, PNTG stock reached the peak price of $31.01 while $30.06 was the lowest point it dropped to. The percentage change in PNTG stock occurred in the recent session was 1.48% while the dollar amount for the price change in PNTG stock was $0.45.

PNTG's industry and sector of operation?

The NASDAQ listed PNTG is part of Medical - Care Facilities industry that operates in the broader Healthcare sector. The Pennant Group, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PNTG?

Mr. John J. Gochnour
Pres & Chief Operating Officer
Ms. Jennifer L. Freeman CPA
Interim Chief Financial Officer
Mr. Derek J. Bunker
Chief Investment Officer, Executive Vice President & Sec.
Mr. Brent J. Guerisoli
Chief Executive Officer & Director
Mr. Brian Wayment
Pres of Cornerstone Healthcare
Mr. Kirk S. Cheney
Gen. Counsel & Corporation Sec.
Mr. Kirk Cheney
Gen. Counsel & Corporation Sec.
Ms. Lynette B. Walbom CPA
Chief Financial Officer

How PNTG did perform over past 52-week?

PNTG's closing price is 45.42% higher than its 52-week low of $21.18 where as its distance from 52-week high of $31.94 is -3.57%.

How many employees does PNTG have?

Number of PNTG employees currently stands at 7,000.

Link for PNTG official website?

Official Website of PNTG is: https://www.pennantgroup.com

How do I contact PNTG?

PNTG could be contacted at phone 208 506 6100 and can also be accessed through its website. PNTG operates from 1675 East Riverside Drive, Eagle, ID 83616, United States.

How many shares of PNTG are traded daily?

PNTG stock volume for the day was 345.84K shares. The average number of PNTG shares traded daily for last 3 months was 268.8K.

What is the market cap of PNTG currently?

The market value of PNTG currently stands at $1.07B with its latest stock price at $30.80 and 34.59M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	7000
Beta	1.28
Sales or Revenue	$544.89M
5Y Sales Change%	0.775%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Care Facilities

PNTG Company Profile and Key Details

Pennant Group

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Key Takeaways

Price Forecast & Outlook

Valuation Metrics